ArticleBMC emergency medicine2026
Investigation of the relationship between shock index and BUN/Albumin ratio with clinical outcomes in patients presenting to the emergency department with upper gastrointestinal bleeding.
Article in BMC emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Timing of endoscopy and its impact on prognosis in patients admitted to the emergency department with upper gastrointestinal bleeding.Irish journal of medical science · 2026Article
- Prognostic Value of BUN-Based Ratios for Mortality and Prolonged Hospitalization in Acute Upper Gastrointestinal Bleeding: Comparison with Established Risk Scores.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate whether the shock index (SI) and blood urea nitrogen (BUN)/albumin ratio (BAR) measured at admission can serve as effective markers for predicting rebleeding and mortality at 28, 90, and 180 days in patients presenting to the emergency department with upper gastrointestinal bleeding (UGIB). MATERIAL-
methodIn this single-center prospective study, patients with UGIB admitted to a tertiary care emergency department between January 1, 2023, and December 31, 2023, were prospectively analyzed. ROC analysis was conducted to assess the predictive performance of SI and BAR for rebleeding and mortality at 28, 90, and 180 days.
resultsA total of 120 patients who met the inclusion criteria were included in the study. The area under the curve (AUC) values for BAR in predicting mortality at 28, 90, and 180 days were 0.83, 0.79, and 0.81, respectively. The corresponding AUC values for the shock index (SI) were 0.66, 0.61, and 0.62. For predicting recurrent upper gastrointestinal bleeding (UGIB) within 28, 90, and 180 days, the AUC values of BAR were 0.74, 0.73, and 0.73, respectively, whereas the AUC values for SI were 0.57, 0.57, and 0.61. In terms of 180-day mortality, age ≥ 65 years [OR: 6.12 (95% CI, 1.86–20.15), p < 0.001] and the presence of comorbidities [OR: 3.79 (95% CI, 1.28–11.27), p < 0.05] were identified as significant risk factors for recurrent UGIB within 180 days. were identified as significant risk factors for recurrent UGIB.
conclusionIn patients with UGIB presenting to the emergency department, BAR demonstrated the highest predictive performance for recurrent UGIB and mortality at 28, 90, and 180 days. Based on these findings, BAR may serve as an effective marker for the follow-up of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.